BELLUOMINI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 60
AS - Asia 28
Totale 331
Nazione #
US - Stati Uniti d'America 243
IT - Italia 34
CN - Cina 22
DE - Germania 7
IE - Irlanda 5
GB - Regno Unito 4
TR - Turchia 4
UA - Ucraina 4
SE - Svezia 3
BE - Belgio 2
IN - India 2
CH - Svizzera 1
Totale 331
Città #
Chandler 34
Fairfield 27
Ashburn 26
New York 17
Woodbridge 16
Houston 15
Ann Arbor 12
Milan 11
Seattle 9
Wilmington 9
Ferrara 7
Jacksonville 7
Shanghai 7
Princeton 6
Beijing 5
Cambridge 5
Dublin 5
Bologna 4
Bremen 4
Izmir 4
Ferrara di Monte Baldo 3
Boardman 2
Brussels 2
Hebei 2
Hyderabad 2
Nanchang 2
Nanjing 2
Pasadena 2
Verona 2
Agna 1
Changsha 1
Falls Church 1
Jiaxing 1
Kunming 1
London 1
Los Angeles 1
Mountain View 1
Redwood City 1
San Diego 1
Volketswil 1
Totale 260
Nome #
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: Implications for personalised treatment 119
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 64
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination 42
Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities? 38
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke 32
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 26
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 19
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report 9
Totale 349
Categoria #
all - tutte 2.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 4 8
2019/202051 10 1 2 10 2 3 5 2 4 7 1 4
2020/202151 4 2 1 4 3 4 3 6 8 7 4 5
2021/202250 2 0 0 2 1 5 5 5 5 5 4 16
2022/202393 8 4 14 6 20 10 6 11 11 0 2 1
2023/202453 4 8 0 0 2 25 3 8 0 3 0 0
Totale 349